Wuhan General Group (China), Inc.
OTC: WUHN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Jeff Robinson
- Employees
- 700
- Headquarters
- Cape Town, United States
- IPO year
- 2006
- Market cap
- $16.5K
- Website
- https://m2bio.co
Loading WUHN…
Loading profile data…Frequently asked questions about WUHN
What does Wuhan General Group (China), Inc. (WUHN) do?
Wuhan General Group (China), Inc. is a nutraceutical biotechnology company, which engages in the development of alternative plant-based cannabinoids and psilocybin medical research that commercializes a range of cannabidiol and mushrooms-based products under the Dr. AnnaRx, Medspresso and Handcrafted Delights brands. The firm is also engages in...
Where does WUHN trade?
Wuhan General Group (China), Inc. (WUHN) trades on the Other OTC.
What sector is WUHN in?
Wuhan General Group (China), Inc. (WUHN) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Wuhan General Group (China), Inc.?
Jeff Robinson is the chief executive officer of Wuhan General Group (China), Inc. (WUHN).
Where is Wuhan General Group (China), Inc. headquartered?
Wuhan General Group (China), Inc. is headquartered in United States.
Does WUHN pay a dividend?
Wuhan General Group (China), Inc. (WUHN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did WUHN go public?
Wuhan General Group (China), Inc. (WUHN) completed its initial public offering in 2006.